BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11331803)

  • 1. Variations in the treatment culture of nursing homes and responses to regulations to reduce drug use.
    Svarstad BL; Mount JK; Bigelow W
    Psychiatr Serv; 2001 May; 52(5):666-72. PubMed ID: 11331803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nurse-physician communication and quality of drug use in Swedish nursing homes.
    Schmidt IK; Svarstad BL
    Soc Sci Med; 2002 Jun; 54(12):1767-77. PubMed ID: 12113434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities.
    Borson S; Doane K
    Psychiatr Serv; 1997 Oct; 48(10):1289-96. PubMed ID: 9323748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic use in community residential care facilities: A prospective cohort study.
    Lakey SL; Gray SL; Sales AE; Sullivan J; Hedrick SC
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):227-35. PubMed ID: 17062323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic benzodiazepine use in nursing homes: effects of federal guidelines, resident mix, and nurse staffing.
    Svarstad BL; Mount JK
    J Am Geriatr Soc; 2001 Dec; 49(12):1673-8. PubMed ID: 11844002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The OBRA-87 nursing home regulations and implementation of the Resident Assessment Instrument: effects on process quality.
    Hawes C; Mor V; Phillips CD; Fries BE; Morris JN; Steele-Friedlob E; Greene AM; Nennstiel M
    J Am Geriatr Soc; 1997 Aug; 45(8):977-85. PubMed ID: 9256852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been?
    Hughes CM; Lapane KL
    Drugs Aging; 2005; 22(4):339-51. PubMed ID: 15839722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations.
    Shorr RI; Fought RL; Ray WA
    JAMA; 1994 Feb; 271(5):358-62. PubMed ID: 8283585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes.
    Avorn J; Soumerai SB; Everitt DE; Ross-Degnan D; Beers MH; Sherman D; Salem-Schatz SR; Fields D
    N Engl J Med; 1992 Jul; 327(3):168-73. PubMed ID: 1608408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nursing home resources and tranquilizer use among the institutionalized elderly.
    Svarstad BL; Mount JK
    J Am Geriatr Soc; 1991 Sep; 39(9):869-75. PubMed ID: 1885861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic drug prescriptions for nursing home residents.
    Burns BJ; Kamerow DB
    J Fam Pract; 1988 Feb; 26(2):155-60. PubMed ID: 3339319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational study of antipsychotic medication use among long-stay nursing home residents without qualifying diagnoses.
    Phillips LJ; Birtley NM; Petroski GF; Siem C; Rantz M
    J Psychiatr Ment Health Nurs; 2018 Oct; 25(8):463-474. PubMed ID: 29911331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OBRA regulations and the use of psychotropic drugs in long-term care facilities: impact and implications for geropsychiatric care.
    Stoudemire A; Smith DA
    Gen Hosp Psychiatry; 1996 Mar; 18(2):77-94. PubMed ID: 8833576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes.
    Schmidt I; Claesson CB; Westerholm B; Nilsson LG; Svarstad BL
    J Am Geriatr Soc; 1998 Jan; 46(1):77-82. PubMed ID: 9434669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the 1987 federal regulations on the use of psychotropic drugs in Minnesota nursing homes.
    Garrard J; Chen V; Dowd B
    Am J Public Health; 1995 Jun; 85(6):771-6. PubMed ID: 7762708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate use of psychotropic drugs in nursing homes.
    Gurvich T; Cunningham JA
    Am Fam Physician; 2000 Mar; 61(5):1437-46. PubMed ID: 10735348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental illness and psychotropic medication use in the nursing home.
    Arling G; Ryther BJ; Collins T; Zimmerman D
    J Aging Health; 1991 Nov; 3(4):455-72. PubMed ID: 10115034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of cultural values and resident-centered culture change in U.S. nursing facilities.
    Banaszak-Holl J; Castle NG; Lin M; Spreitzer G
    Health Care Manage Rev; 2013; 38(4):295-305. PubMed ID: 22936002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland.
    Hosia-Randell H; Pitkälä K
    Drugs Aging; 2005; 22(9):793-800. PubMed ID: 16156683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is psychotropic medication use related to organisational and treatment culture in residential care.
    Peri K; Kerse N; Moyes S; Scahill S; Chen C; Hong JB; Hughes CM
    J Health Organ Manag; 2015; 29(7):1065-79. PubMed ID: 26556168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.